Abstract:The CYP2A6 gene spans a region of approximately 6 kb pairs consisting of 9 exons and has been mapped to the long arm of chromosome 19 (between 19q12 and 19q13.2). The CYP2A6 protein has 494 amino acids and is an important hepatic Phase I enzyme that metabolizes approximately 3% of therapeutic drugs (n > 30; e.g. valproic acid, pilocarpine, tegafur, fadrozole, ifosfamide, cyclophosphamide, nicotine, tamoxifen, promazine, propofol, and cisapride), environmental toxicants (e.g. gasoline additives), and many procarcinogens such as nitrosamines and aflatoxin B(1). This enzyme also participates in the biotransformation of several endogenous compounds such as retinoid acids and steroids. Because CYP2A6 is responsible for 70-80% of the initial metabolism of nicotine, CYP2A6 has been proposed to be a novel target for smoking cessation. Site-directed mutagenesis and homology modeling studies have identified a number of amino acids (e.g. F300, A301, S208, S369, and L370) that play a role in substrate recognition and binding. CYP2A6 shows a crystal structure with a compact, hydrophobic active site with Asn297 serving as one hydrogen bond donor and orienting substrates for regio-selective oxidation. CYP2A6 contains the second smallest active site cavity among the human CYPs with known structures. The regulation mechanism of CYP2A6 expression is not fully understood, but available data suggest that several nuclear receptors including constitutive androstane receptor, pregnane X receptor and glucocorticoid receptor are involved in its regulation. Pilocarpine and tranylcypromine are commonly used as selective competitive inhibitors of CYP2A6. Selegiline, methoxsalen, (R)-(+) menthofuran and decursinol angelate are mechanism-based inhibitors of CYP2A6. Both in vitro and in vivo studies have demonstrated a wide (20- to >100-fold) interindividual variation in CYP2A6 expression and activity, which is due primarily to genetic polymorphisms in the CYP2A6 gene, but CYP2A6 activity is also modified by certain drugs and pathological and environmental factors. To date, more than 36 variant alleles (*1B through *37) of the CYP2A6 gene have been identified. There have been 278 SNPs found in the CYP2A6 upstream sequence, 8 introns and 9 exons in NCBI dbSNP. Polymorphism of CYP2A6 has been associated with smoking behavior, drug clearance and lung cancer risk. Further studies are warranted to explore the role of CYP2A6 in clinical practice, drug development and toxicology.

Cloning of a new human cytochrome P450 2A6 cDNA

Cloning of Human Cytochrome P450 2A6 Cdna and Its Expression in Mammalian Cells

Expression and Characterization of Human Cytochrome P450 1A2

The Full-Length Cdna of CYP1A1 Gene Cloning by T Vector and Sequencing

CLONING AND MOLECULAR CHARACTERIZATIONS ANALYSES OF CYP450 FROM Orychophrogmus violaceus (L.)

Cloning of CYP2J2 Gene and Identification of Functional Polymorphisms

Study Heterogenous Expression and Activity Determination of Human Cytochrome P450 2B6

Cloning and Expression of Cytochrome P4501A Gene from Liver of the Red Sea Bream(Pagrus major)

Detection of Cytochrome P450 2D6 Allele CYP2D6*6 by Using Allele-specific Amplification

Cloning and Sequence Analysis of Human Transferrin Gene

Cloning of UGT1A9 Cdna from Liver Tissues and Its Expression in CHL Cells

Cloning and sequence of cDNA fragments of cytochrome P450 from Ostrinia furnacalis

Analysis of Cytochrome P450 2D6 Enzyme Deficient Allele CYP2D6T by Allele Specific Amplification.

[Cloning and Tissue Expressive Pattern Analysis of the Human Ribosomal S6 Kinase-Rps6ka5 Cdna].

Construction of Eukaryotic Expression Plasmids Containing Green Fluorescent Protein Gene and CYP19 WT or Its Variants

Cloning of a Novel Gene Fragment Related to P62dok-Ptb Domain

Cloning and identification of human gene 5 transactivated by nonstructural protein 5A of hepatitis C virus

Construction of human CYP2C19 gene polymorphism eukaryotic expression vector and establishment of stably transfected HepG2 cell line expressing human CYP2C19

Cloning,sequencing,and expression of cDNA fragments of CYP4G2 from Xylotechus rusticus L.(Coleoptera:Cerambycidae) in Escherichia coli

Structure, Function, Regulation and Polymorphism of Human Cytochrome P450 2A6

Cloning of the full-length cDNA sequence of a novel human UCA1 spliced variant